[EN] COMBINATION THERAPY FOR TREATING MPS1<br/>[FR] POLYTHÉRAPIE POUR LE TRAITEMENT DE LA MPS1
申请人:GAIN THERAPEUTICS SA
公开号:WO2021156774A1
公开(公告)日:2021-08-12
The application is directed to compounds of formula (I) and their salts and solvates, wherein B, R1, R2, R3, R3', R4, R4', and R5 are as set forth in the specification, as well as to methods for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of, e.g., MPS1, optionally in combination with α-L-iduronidase or an analog or variant thereof, e.g., laronidase.
[EN] AZABICYCLE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF<br/>[FR] DÉRIVÉS D'AZABICYCLE, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION<br/>[ZH] 氮杂双环衍生物及其制备方法和用途
申请人:SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD